Creative Medical Technology Holdings Inc. (CELZ) - Gross Profitability

CELZ (Creative Medical Technology) - company brandmark

Creative Medical Technology (CELZ) specializes in regenerative therapy, having earned recognition in the treatment of reproductive pathologies. The company acquires clients through urological centers, although strict FDA oversight limits expansion. The model scales via the licensing of patents to clinics. Historical gross margins demonstrate effective cost management, while -3245.60 captures a new level mark.

Return on Gross Profit: Creative Medical Technology Holdings Inc. (CELZ) for 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for creativemedicaltechnology.com (CELZ)

- current quotes and average value forecast:
Fundamental valuation:Creative Medical Technology
Core merchandise of Creative Medical Technology

For Creative Medical Technology (CELZ), the gross margin reflects the efficiency of monetizing cellular technologies amid minimal geopolitical risks and the protection of patents in the US. By analyzing the current gross margin level, an investor can see the portion of revenue remaining after deducting direct production costs, which determines the business's ability to scale. Sharp fluctuations in this indicator signal cost instability, warning of the risk of capital overheating.